BriaCell Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 6, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Cap	40	1	0	1	1	1
Market Cap Growth	36.49%	1445.49%	-87.17%	7.72%	27.95%	1392.31%
Enterprise Value	7.66	-17	-1.07	-20.54	-40.38	-56.75
Last Close Price	4.91	0.75	0.75	6.69	6.50	5.08
PB Ratio	1.24	0.08	-0.04	-0.19	0.06	0.02
P/TBV Ratio	0.66	0.02	-	-	0.07	0.01
EV/EBITDA Ratio	-	0.63	0.03	0.88	2.64	8.15
EV/EBIT Ratio	-	0.62	0.03	0.88	2.64	8.14
EV/FCF Ratio	-	0.60	0.04	0.86	3.23	7.32
Net Debt / Equity Ratio	-0.95	-1.00	0.36	5.63	-3.97	-2.07
Net Debt / EBITDA Ratio	0.77	0.66	0.03	0.91	2.69	8.23
Net Debt / FCF Ratio	0.74	0.63	0.04	0.90	3.29	7.39
Quick Ratio	7.07	5.01	0.49	14.96	43.64	102.88
Current Ratio	7.07	5.01	0.49	14.96	45.00	103.81
Return on Equity (ROE)	-190.19%	-362.56%	152.63%	-619.75%	-141.25%	-114.78%
Return on Assets (ROA)	-162.91%	-197.69%	-201.78%	-66.74%	-30.39%	-23.82%
Return on Invested Capital (ROIC)	-2038.57%	-1380.42%	-1053.18%	-989.19%	-3640.60%	-1844.83%
Return on Capital Employed (ROCE)	-194.77%	-338.31%	-280.40%	-69.47%	-30.85%	-25.82%
Buyback Yield / Dilution	-1260.31%	-285.70%	-5.35%	-0.81%	-242.82%	-533.09%
Total Shareholder Return	-1260.31%	-285.70%	-5.35%	-0.81%	-242.82%	-533.09%